Universal Health Services (UHS) FY2024 10-K Annual Report
Universal Health Services (UHS) 10-K annual report for fiscal year 2024, filed with SEC EDGAR on Feb 26, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Universal Health Services FY2024 10-K Analysis
Business Overview
- • Core business model: Operates acute care hospitals and behavioral health facilities providing healthcare services across the U.S.
- • No new products, services, or segments introduced or emphasized in this filing year
- • Continued reliance on longstanding advisory and lease agreements with Universal Health Realty Income Trust detailed in updated exhibits
- • No updated quantitative metrics disclosed in business section; filings focus on legal, governance and financial documentation updates
- • Filing primarily updates incorporation by reference of Proxy Statement sections and multiple amendments to Credit Agreement and indentures through 2024
Management Discussion & Analysis
- • Net revenues $1.58B from UK behavioral health facilities in 2024, up from $1.52B in 2023 (44% of consolidated revenues vs 43%)
- • Acute care and outpatient segment revenue 56% of consolidated in 2024, down 1 point from 57% in 2023
- • Total UK behavioral health assets $1.358B as of Dec 31, 2024 vs $1.327B in 2023
- • No margins or profitability percentages disclosed in this section
- • Forward-looking statements highlight regulatory, competitive, and healthcare industry risks impacting future performance
Risk Factors
- • Legal risk: Ongoing litigation Pavilion and Cumberland cases with $221M insurance coverage remaining, potential material adverse impact if coverage exhausted
- • Macroeconomic risk: Inflationary pressures on personnel costs and operating expenses could increase costs faster than reimbursement, risking capital resource depletion
- • Supply chain risk: Proposed/new significant tariffs on imported pharmaceuticals and medical devices could escalate costs and disrupt supply chains
- • Competitive risk: Increased hospital physician costs in ER and anesthesiology areas, with mitigation efforts only moderately effective, risking operating results
- • Financial risk: Elevated borrowing costs from recent interest rate increases have significantly increased interest expense, reducing free cash flow
Universal Health Services FY2024 Key Financial MetricsXBRL
Revenue
$15.8B
▲ +10.8% YoY
Net Income
$1.1B
▲ +59.1% YoY
Operating Margin
10.6%
▲ +240bp YoY
Net Margin
7.2%
▲ +219bp YoY
ROE
17.1%
▲ +546bp YoY
Total Assets
$14.5B
▲ +3.6% YoY
EPS (Diluted)
$16.82
▲ +64.4% YoY
Operating Cash Flow
$2.1B
▲ +63.0% YoY
Source: XBRL data from Universal Health Services FY2024 10-K filing on SEC EDGAR. All figures in USD.
Other Universal Health Services Annual Reports
Get deeper insights on Universal Health Services
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.